Penumbra (PEN) EBT Margin Growth (1y) (2015 - 2026)
Penumbra (PEN) EBT Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -287.00 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -464.00 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 772.00 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 584.00 |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn | -241.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -241.00 |
| Dec 31, 2025 | 246.00 |
| Sep 30, 2025 | 154.00 |
| Jun 30, 2025 | 3,936.00 |
| Mar 31, 2025 | 828.00 |
| Dec 31, 2024 | 65.00 |
| Sep 30, 2024 | 830.00 |
| Jun 30, 2024 | -3,348.00 |
| Mar 31, 2024 | 166.00 |
| Dec 31, 2023 | 1,018.00 |
| Sep 30, 2023 | 349.00 |
| Jun 30, 2023 | 803.00 |
| Mar 31, 2023 | 609.00 |
| Dec 31, 2022 | 2,330.00 |
| Sep 30, 2022 | -267.00 |
| Jun 30, 2022 | -610.00 |
| Mar 31, 2022 | -987.00 |
| Dec 31, 2021 | -1,977.00 |
| Sep 30, 2021 | 1,715.00 |
| Jun 30, 2021 | 2,174.00 |